安宅信康

Recent publications · Crossref

5 total works indexed

1. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

   · 2019 · cited 1,871x

2. Mapping the human genetic architecture of COVID-19

   · 2021 · cited 816x

3. RosettaScripts: A Scripting Language Interface to the Rosetta Macromolecular Modeling Suite

   · 2011 · cited 658x

4. Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study

   · 2014 · cited 617x

5. Principles for designing ideal protein structures

   · 2012 · cited 574x

via Crossref · CC0

Wikidata facts